Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins
| Authors | |
|---|---|
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY |
| MU Faculty or unit | |
| Citation | |
| web | https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824 |
| Doi | http://dx.doi.org/10.1080/14787210.2020.1816824 |
| Keywords | Antimicrobials; bacteriocin; colicin; microcin; Escherichia; E; coli; probiotic; Shigella; virulence; diarrhea |
| Description | Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins. |
| Related projects: |